Navigation Links
EPA Awards Lovelace Respiratory Research Institute $500,000 for Air Quality Research
Date:3/4/2009

Focus on air pollutant components as possible link to cardiovascular disease

ALBUQUERQUE, N.M., March 4 /PRNewswire/ -- The Environmental Protection Agency has awarded $500,000 to the Lovelace Biomedical and Environmental Research Institute, a subsidiary of Lovelace Respiratory Research Institute, LRRI. The award is to develop environmental health indicators, or "biomarkers" of cardiovascular disease caused by air pollution. Exposures to particulate matter, ozone, and diesel exhaust have been identified as a possible cause for cardiovascular disease in humans, but there is limited information on which cardiovascular biomarkers are most altered by pollutant exposures. Better information can enhance an understanding of how air pollution causes vascular diseases, such as atherosclerosis, as well as point towards who in the community may be most vulnerable. It would allow researchers to better pinpoint which sources of pollution have the greatest impact on health.

The Lovelace Biomedical and Environmental Research Institute will conduct research to develop novel and more specific markers for acute exposure to humans. The Institute's research team will be headed by Matthew Campen, Ph.D., one of the more than 100 scientists working on respiratory disease research at LRRI. Dr. Campen says, "We have known for a long time that air pollution contributes to respiratory disease. This generous grant from the EPA endorses our work and will advance our understanding of the relationship between air pollution and one of the major killers in America, cardiovascular disease."

Project activities involved in this research will include identifying susceptible individuals, classifying causal components of the complex air pollution mixture, and developing a better understanding of the biological mechanisms involved in air pollution-induced cardiovascular toxicity. As a result of data collected from this study, LRRI hopes to identify individuals who could be at risk of developing atherosclerosis, a chronic arterial inflammatory disease which may lead to heart attacks or stroke.

About Lovelace Respiratory Research Institute

The Lovelace Respiratory Research Institute (LRRI) is a private, biomedical research organization dedicated to improving public health through research on the prevention, treatment and cure of respiratory disease. Since 1947, LRRI is committed to curing respiratory diseases through research aimed at understanding their causes and biological mechanisms; assessing and eliminating exposures to respiratory health hazards; and developing improved therapeutics, vaccines, and diagnostics. LRRI is based in Albuquerque, New Mexico, employees 100 Ph.D. - level scientists and is a $70 million company.

    Contact:    Sandy McKay, LRRI, smckay@LRRI.org-505-348-9486
                Kyla Thompson, PR, kyla@kylathompson.com-505-341-0699


'/>"/>
SOURCE Lovelace Respiratory Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Weed Science Society of America Announces Winners in Annual Scientific Awards Program
2. P2R Associates Presented with Eight MarCom Awards for Client Strategic Communication Programs
3. SPIE and Laurin Publishing Announce Prism Awards Finalists
4. Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program
5. Red Herring Awards ProGenTech Limited for the 2008 Red Herring Asia 100
6. BioMS Medical recognized at Scrip Awards 2008
7. SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London
8. National Ergonomics Expo Sees 86% On-Site Exhibitor Renewal Rate for 2009; New Products from Contour Design, Equipois, Goldtouch and Herman Miller Win 2008 NECE Attendees Choice New Product Awards
9. Frost & Sullivan Awards Baxters BioPharma Solutions Business the 2008 North American Customer Service Leadership of the Year Award
10. USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities
11. Metastorm Selected as a Finalist in ACG Deal of the Year Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" ... that will be presented at the Company,s Annual and Special ... of Shareholders will take place on Thursday, December 15, 2016 ... Glenn Hall (Room EC1040), 4825 Mount Royal Gate SW, ... (MST). A notice of meeting and management information circular, containing ...
(Date:12/7/2016)... , Dec. 7, 2016  Vyriad Inc. announced ... to the company,s Board of Directors. "We ... we build our business and develop our oncolytic viruses ... therapy," said Stephen Russell , MD, PhD, CEO ... , share our vision and passion for making a ...
(Date:12/7/2016)... , December 7, 2016 Regen BioPharma ... International Journal of Molecular Sciences a team of scientists in ... ] have demonstrated that expression of NR2F6 in patients ... tested for NR2F6 in patient,s cervical cancer tissue as well ... "This is an interesting study and the first ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... to an early access program for SmartBiome -- a novel metagenomic deep-sequencing ... simultaneous specific enrichment and detection of hundreds of different genes. The selective ...
Breaking Biology Technology:
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market by ... Area, End User, And Region - Global Forecast to 2021", published by MarketsandMarkets, ... to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate (CAGR) ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
Breaking Biology News(10 mins):